NPS PHARMACEUTICALS INC's ticker is and the CUSIP is 62936P903. A total of 5 filers reported holding NPS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $4,768,000 | +8.6% | 133,300 | -21.1% | 0.07% | +5.9% |
| Q3 2014 | $4,391,000 | +2.1% | 168,900 | +29.8% | 0.07% | +3.0% |
| Q2 2014 | $4,300,000 | +13.5% | 130,100 | +2.8% | 0.07% | +3.1% |
| Q1 2014 | $3,789,000 | -11.1% | 126,600 | -9.8% | 0.06% | 0.0% |
| Q4 2013 | $4,260,000 | +44.0% | 140,300 | +50.9% | 0.06% | +12.3% |
| Q3 2013 | $2,958,000 | +195.8% | 93,000 | +40.5% | 0.06% | +128.0% |
| Q2 2013 | $1,000,000 | – | 66,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pentwater Capital Management LP | 620,600 | $22,199,000 | 0.16% |
| GROUP ONE TRADING, L.P. | 133,300 | $4,768,000 | 0.07% |
| SABBY MANAGEMENT, LLC | 594 | $2,125,000 | 0.07% |
| SIMPLEX TRADING, LLC | 526 | $369,000 | 0.04% |
| Citadel Advisors | 69,600 | $2,490,000 | 0.00% |